First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.2 USD -3.45% Market Closed
Updated: Mar 28, 2024

ADC Therapeutics SA
Net Issuance of Common Stock

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

ADC Therapeutics SA
Net Issuance of Common Stock Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Net Issuance of Common Stock
$5.9m
CAGR 3-Years
-76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Net Issuance of Common Stock
CHf43.8m
CAGR 3-Years
579%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Net Issuance of Common Stock
$62.7m
CAGR 3-Years
-60%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Net Issuance of Common Stock
CHf2m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
-26%
Idorsia Ltd
SIX:IDIA
Net Issuance of Common Stock
CHf360k
CAGR 3-Years
-35%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Net Issuance of Common Stock?
Net Issuance of Common Stock
5.9m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Net Issuance of Common Stock amounts to 5.9m USD.

What is ADC Therapeutics SA's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 3Y
-76%

Over the last year, the Net Issuance of Common Stock growth was 0%. The average annual Net Issuance of Common Stock growth rates for ADC Therapeutics SA have been -76% over the past three years .